EliseAI Funding: $350M Round Lifts AI Startup to $4B Valuation

A near-doubling in about a year

EliseAI, the New York company selling AI automation to apartment operators and medical practices, has raised $350 million at a $4 billion valuation 23. Andreessen Horowitz and Bessemer Venture Partners led the round. Ontario Teachers' Pension Plan, Sapphire Ventures and Navitas Capital also participated 12. The deal was announced September 29, 2026, and one outlet describes it as a Series F 24.

The jump is steep. EliseAI was valued at roughly $2.2 billion about 13 months earlier 4, after a funding round that one report puts at $250 million in August 2025 1. The company reportedly now brings in more than $200 million in annual recurring revenue 4. Its software touches about one in every six U.S. apartments 14.

Where the money goes

The stated plan is simple. EliseAI says it will automate more of its customers' operations and expand its engineering, deployment and sales teams across North America 2. It is adding San Francisco as a second engineering hub next to its New York headquarters 12. One report lists a wider footprint that includes Chicago, Austin, Boston and Toronto 3.

Coverage of the round splits by audience. Real estate outlets focus on leasing calls, maintenance scheduling and renewal paperwork 4. Healthcare press focuses on the patient-facing assistant 3. That assistant schedules appointments, collects demographic details, checks insurance eligibility, applies a practice's booking rules, matches patients to providers, and creates or matches records in the electronic health record 3.

EliseAI frames both markets the same way. Housing and healthcare are the two largest expenses for American households, it argues, and both run on thin margins, heavy regulation and stretched staff while being poorly served by technology 2.

The playbook behind the pitch

The most revealing detail is not in the press release. EliseAI has written a 262-page manual that lays out a staged path for customers [1]:

• Automate administrative tasks first.
• Then automate leasing.
• Finally, shrink payroll by eliminating jobs.

The manual also includes templates meant to keep the remaining employees from being alarmed as their functions are handed to software 1.

This puts the company's language about "AI teammates" 4 in a different light. Investors at a $4 billion price are not paying for a productivity tool alone. They are paying for software that turns into labor savings on a property manager's books. The playbook says so plainly. It also shows the company expects worker unease and has prepared material to manage it.

For the multifamily sector, that matters. The cost of leasing offices and front-desk staff could become a target to cut rather than a fixed expense. In healthcare, the same logic would apply to scheduling and intake staff, though the reporting does not show EliseAI pitching identical cuts there.

Is the valuation disciplined?

One analysis puts the deal at roughly 20 times ARR 5. It argues that is restrained compared with the 30 to 35 times forward revenue that many AI-native startups command with far less usage to point to 5. Another notes that EliseAI's growth has been slower than the typical venture-backed AI story. The company was founded in 2017, nine years before this round 4.

Both points support the case that this is a company with real revenue and real deployment, not a pure bet on future potential.

The investor list matters too. This is Ontario Teachers' first investment in EliseAI. That suggests pension capital is now willing to join late-stage vertical AI rounds that used to be limited to pre-IPO companies 5.

The distribution fight ahead

The clearest risk comes from incumbents. RealPage, AppFolio and Entrata are building their own AI features directly into the property-management accounts EliseAI wants to win 5. These companies already own the system of record for many landlords. That is a real advantage: an operator may accept "good enough" automation from a vendor it already pays rather than add another one.

The takeaway

The financing looks less like an AI hype round and more like a wager on a specific business model: selling workforce reduction to industries with thin margins. The revenue base and comparatively modest multiple make the valuation easier to defend than many AI deals.

Two questions will decide whether it holds up. First, can EliseAI win distribution against entrenched platforms? Second, will its customers carry out the playbook's final stage, and how will employees, tenants and patients respond if they do?